Pulse Biosciences, Inc.
PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company wasā¦ read more
Healthcare
Medical Instruments & Supplies
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$15.26
Price+6.12%
$0.88
1Y
Price
Market Cap
$1.034b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-22243.0%
EBITDA Margin-22540.7%
Net Profit Margin-15233.7%
Free Cash Flow MarginRevenue
$86k
-
1y CAGR-33.3%
3y CAGR-37.7%
5y CAGREarnings
-$74.733m
-39.5%
1y CAGR-12.9%
3y CAGR-7.6%
5y CAGREPS
-$1.15
-25.0%
1y CAGR+6.4%
3y CAGR+11.0%
5y CAGRBook Value
$92.694m
$108.765m
Assets$16.071m
Liabilities$7.890m
DebtDebt to Assets
7.2%
-0.1x
Debt to EBITDAFree Cash Flow
-$48.774m
-33.7%
1y CAGR-4.5%
3y CAGR-0.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company